Clinical and molecular profile of a Brazilian cohort of patients with classical BCR-ABL1-negative myeloproliferative neoplasms.
Hematology, Transfusion And Cell Therapy
Porto-Soares, Moysés Antonio MA; de Oliveira, Rafael Daltro RD; Cortopassi, Gabriel Macedo GM; Machado-Neto, João Agostinho JA; Palma, Leonardo Carvalho LC; Figueiredo-Pontes, Lorena Lobo de LL
Publication Date: 2020
Variant appearance in text: JAK2: 1611_1616delTCACAA; Phe537_Lys539delinsLeu
Mechanistic insights into activation and SOCS3-mediated inhibition of myeloproliferative neoplasm-associated JAK2 mutants from biochemical and structural analyses.
The Biochemical Journal
Varghese, Leila N LN; Ungureanu, Daniela D; Liau, Nicholas P D NP; Young, Samuel N SN; Laktyushin, Artem A; Hammaren, Henrik H; Lucet, Isabelle S IS; Nicola, Nicos A NA; Silvennoinen, Olli O; Babon, Jeffrey J JJ; Murphy, James M JM